PNEUMONIA (LUNG INFLAMMATION) — A SERIOUS THREAT TO CHILDREN’S LIVES
Keywords:
Pneumonia, lung inflammation, respiratory failure, hypoxia, pediatric mortality, risk factors, prevention.Abstract
Pneumonia (inflammation of the lungs) remains one of the leading causes of
morbidity and mortality among children worldwide, particularly in low- and middle
income countries. The disease is characterized by inflammation of the pulmonary
parenchyma, impaired gas exchange, and progressive respiratory insufficiency. Young
children, especially neonates and preterm infants, are at high risk due to immature
immune function and increased susceptibility to hypoxia. Early diagnosis, appropriate
antimicrobial therapy, vaccination, adequate nutrition, and supportive oxygen therapy
are critical components in reducing complications and mortality. Recent evidence
suggests that integrated preventive strategies combining immunization programs,
nutritional support, and timely clinical intervention significantly improve pediatric
outcomes [1, 2].
References
1. World Health Organization. Pneumonia in children – Key facts. WHO Fact
Sheet.
2022.
Available
at:
https://www.who.int/en/news-room/fact
sheets/detail/pneumonia
2. Rudan I., Boschi-Pinto C., Biloglav Z., Mulholland K., Campbell H.
Epidemiology and etiology of childhood pneumonia. Bull World Health Organ.
2008;86(5):408-416.
Available
at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647437/
3. Smith D.K., Kuckel D.P., Recidoro A.M. Community-Acquired Pneumonia in
Children: Rapid Evidence Review. Am Fam Physician. 2021;104(6):645-654.
Available at: https://pubmed.ncbi.nlm.nih.gov/34913645/
